期刊文献+

青岛地区革兰阴性杆菌的分布及耐药性监测 被引量:7

Distribution and Antibiotic Resistance of Gram-negative Bacilli in Qingdao:A Surveillance
下载PDF
导出
摘要 目的了解青岛地区常见革兰阴性杆菌的种类、分布及耐药状况,为临床用药提供依据。方法收集青岛地区4所医院临床分离的2362株革兰阴性杆菌,采用ATB Expression自动细菌鉴定系统对菌种进行鉴定,用K-B法进行药物敏感性实验。结果分离出的革兰阴性杆菌中,主要以大肠埃希菌(ECO)、铜绿假单胞菌(PAE)、肺炎克雷伯菌(KPN)、不动杆菌属(AC-)、阴沟肠杆菌(ECL)多见;大多数革兰阴性杆菌对广谱青霉素、第三代头孢菌素、氨基糖苷类和喹诺酮类抗菌药物的耐药率高;头孢吡肟(FEP)对革兰阴性非发酵菌抗菌作用差,对肠杆菌科细菌耐药率较低,为17.5%-33.9%;头孢哌酮/舒巴坦(CFS)和哌拉西林/他唑巴坦(TZP)对革兰阴性杆菌的抗菌作用强,耐药率分别为9.9%-24.6%和9.3%-29.2%;亚胺培南(IMP)对革兰阴性杆菌的抗菌活性最强,除PAE外,细菌耐药率均〈5%。结论革兰阴性杆菌对常用抗菌药物耐药性较高,开展地区性细菌耐药监测十分重要。 OBJECTIVE To investigate the distribution and resistance of Gram-negative bacilli in Qingdao and for offering reasonable evidence to antibiotics therapy. METHODS Totally 2362 strains of Gram-negative bacilli were collected from 4 hospitals in Qingdao. The identification was analyzed by ATB Expression automatic microbiology analytical instrument system. The bacterial susceptibility test was done by Kirby-Bauer agar diffusion method. RESULTS Among 2362 isolates, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneurnoniae, Acinetobacter spp, and Enterobacter cloacae were the main. Most of Gram-negative bacilli were high resistant to broadspectrum penicillins, third-generation cephalosporins, aminoglycosides and quinolones. Cefepime had less activity against nonfermentative Gram-negative organisms and low resistant to Enterobacteriaceae bacteria (17.5-33.9%). Cefoperazone/sulbactam and piperacillin/tazobactam showed greater activity against Gram-negative bacilli, their resistant rates were 9.9-24.6% and 9.3-29.2%, respectively. Imipenem was the most active agent against Gram- negative bacilli (except Pseudornonas aeruginosa), the resistant rates were 0-4.9%. CONCLUSIONS Resistance rates of Gram-negative bacilli are high. It is urgent to establish a regional surveillance system on bacterial resistance.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2007年第9期1138-1140,共3页 Chinese Journal of Nosocomiology
关键词 革兰阴性杆菌 抗菌药物 耐药性 Gram-negative bacilli Antibiotics Antimicrobial resistance
  • 相关文献

参考文献6

二级参考文献27

  • 1李革,中华医院感染学杂志,1999年,9卷,1期,10页
  • 2房方,中华医院感染学杂志,1998年,8卷,3期,185页
  • 3Ohya S,Fukuoka T,Masuda N,et al.Microbiological evaluation of panipenem/betamipron,a new parenterally active carlapenem V.increase in susceptibility of pseudomonas aeruginosa to panipenem in low.amino-acid media.Chemo Therapy,1991,39(S-3):132
  • 4Levy SB.The Challenge of antibiotic resistance[J].Scientific American,1998,278:46-53
  • 5Jones RN,Pfaller MA.Bacterial resistance: A worldwide problem[J].Diagn.Microbiol Infect Dis,1998,31:379-388
  • 6Williams RJ,Ryan MJ.Surveillance of antimicrobial resistance-an international perspective[J].Br Med J,1998,317:651
  • 7Am Society Microbiol.Report of the ASM task force on antibiotic resistance[J].Antimicrob Agents,Chemother,1995,Supplement: 1-23
  • 8World Health Organization.WHO global strategy for containment of antimicrobial resistance.WHO/CDS/CSR/DRS/2001.2[J]
  • 9Wang H,Huebner R,Chen M,et al.Antibiotic susceptibility patterns of Streptococcus pneumoniae in China and comparison of MICs by agar dilution and E test methods[J].Antimicrob Agents Chemother,1998,42:2633-2636
  • 10Sahm DF,Karlowsky JA,Kelly LJ,et al.Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States:2-year longitudinal analysis[J].Antimicrob Agents Chemother,2001,45:1037-1042

共引文献393

同被引文献31

  • 1刘文静,张小江,杨文航,谢秀丽,王贺,杨启文,徐英春,陈民钧.2008年北京协和医院细菌耐药性监测结果分析[J].中国感染与化疗杂志,2010,10(4):290-296. 被引量:20
  • 2李和姐,钱倩健,施晓群,吴佩雯,倪语星.瑞金医院医院感染与全国医院感染监测比较分析[J].中华医院感染学杂志,2004,14(2):144-147. 被引量:56
  • 3杨志辉,牟静,阮菊琴,刘虹,陈方慧,赵兵.2000-2004年住院患者医院感染调查[J].中华医院感染学杂志,2006,16(7):755-757. 被引量:59
  • 4Simhon A, Rahav G, Shazberg G, et al. Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel [J]. J Clin Microbiol, 2001,39(1):389-390.
  • 5Rodriguez Hernandez MJ, Cuberos L, Pichardo C, etal. Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains[J]. J Antimicrob Chemother, 2001,47(4):479-482.
  • 6Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenern-resistant Acinetobacter baumannii treated with ampicillin/sulbactam[J]. Int J Antimieroh Agents,2003,21(1) :58-61.
  • 7Simbon A, Rahav G, shazberg G,et al. Acinetobacter baumanni at a tertiary-care teaching in Jerusalem, Israel[ J ]. J Clin Microbiol, 2001 ;39 ( 1 ) :389-91.
  • 8Rodriguez-Hemandcz M J, Cuberos L, Pichardo C,et al. Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains [ J ]. J Antimicrob Chemother,2001 ;47 (4) :479- 82.
  • 9Levin AS, Levy CE, Manriqne AE ,et al. Severe nosocomial infections with imipenem-resistant. Acinetobacter baumannii treated with ampicillin/sulbactam[J]. Int J Antimicrob Agents,2003 ;21 (1) :58-62.
  • 10Ariffin H, Navaratnam P,Kee TK, et al. Antibiotic resistance patterns in nosocomial Gram negative bacterial infection in units with heavy antibiotic usage[J]. J Trop Pediatr,2004,50 (I) :26-31.

引证文献7

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部